115 related articles for article (PubMed ID: 3053205)
21. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
[TBL] [Abstract][Full Text] [Related]
22. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms.
Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J
Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907
[TBL] [Abstract][Full Text] [Related]
23. Tumour associated antigens in diagnosis of serous effusions.
Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
[TBL] [Abstract][Full Text] [Related]
24. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J
Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527
[TBL] [Abstract][Full Text] [Related]
25. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
[TBL] [Abstract][Full Text] [Related]
26. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
[TBL] [Abstract][Full Text] [Related]
27. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
[TBL] [Abstract][Full Text] [Related]
28. Improvement of tumor cell detection using a pool of monoclonal antibodies.
Tagliabue E; Porro G; Barbanti P; Della Torre G; Ménard S; Rilke F; Cerasoli S; Colnaghi MI
Hybridoma; 1986; 5(2):107-15. PubMed ID: 2424821
[TBL] [Abstract][Full Text] [Related]
29. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. II. Tissue specificity and reactivity.
Kutteh WH; Doellgast GJ
J Natl Cancer Inst; 1986 May; 76(5):797-804. PubMed ID: 3517453
[TBL] [Abstract][Full Text] [Related]
30. Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma.
Mottolese M; Venturo I; Digiesi G; Perrone Donnorso R; Bigotti A; Muraro R; Aluffi A; Natali PG
Br J Cancer; 1990 Apr; 61(4):626-30. PubMed ID: 2184879
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
Singer S; Boddington MM; Hudson EA
J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical markers in the identification of metastatic breast cancer.
de Almeida PC; Pestana CB
Breast Cancer Res Treat; 1992; 21(3):201-10. PubMed ID: 1325217
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
[TBL] [Abstract][Full Text] [Related]
34. [Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusion studied by thoracoscopy and biopsy].
Neubauer A; Thalmann U; Musch R; Grosser H; Loddenkemper R; Huhn D
Klin Wochenschr; 1987 May; 65(9):400-6. PubMed ID: 3298829
[TBL] [Abstract][Full Text] [Related]
35. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate].
Zhang JR; Zhang XY; Chen XT
Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
[TBL] [Abstract][Full Text] [Related]
37. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3.
Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J
Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191
[TBL] [Abstract][Full Text] [Related]
38. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
Flynn MK; Johnston W; Bigner S
Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
[TBL] [Abstract][Full Text] [Related]
39. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
40. Identification of the primary site of metastatic adenocarcinoma in serous effusions. Value of an immunocytochemical panel added to the clinical arsenal.
Longatto Filho A; Alves VA; Kanamura CT; Nonogaki S; Bortolan J; Lombardo V; Bisi H
Acta Cytol; 2002; 46(4):651-8. PubMed ID: 12146025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
